Page 32 - GPD-3-4
P. 32

Gene & Protein in Disease                                          GLUT5 in cancer development and therapy



            22.  Tappy L. Metabolism of sugars: A window to the regulation   34.  Cui Y, Tian J, Wang Z,  et al. Fructose-induced mTORC1
               of glucose and lipid homeostasis by splanchnic organs. Clin   activation promotes pancreatic cancer progression through
               Nutr. 2021;40:1691-1698.                           inhibition of autophagy. Cancer Res. 2023;83(24):4063-4079.
               doi: 10.1016/j.clnu.2020.12.022                    doi: 10.1158/0008-5472.CAN-23-0464
            23.  Nakagawa T, Lanaspa MA, Millan IS,  et al. Fructose   35.  Huang X, Fang J, Lai W,  et al. IL-6/STAT3 axis activates
               contributes to the Warburg effect for cancer growth. Cancer   Glut5 to regulate fructose metabolism and tumorigenesis.
               Metabol. 2020;8:16.                                Int J Biol Sci. 2022;18:3668-3675.
               doi: 10.1186/s40170-020-00222-9                    doi: 10.7150/ijbs.68990
            24.  Vaupel  P,  Multhoff  G.  Revisiting  the  Warburg  effect:   36.  Lu C, Ren C, Yang T, et al. Fructose-1, 6-bisphosphatase 1 interacts
               Historical dogma versus current understanding. J Physiol.   with NF-κB p65 to regulate breast tumorigenesis via PIM2
               2021;599:1745-1757.                                induced phosphorylation. Theranostics. 2020;10:8606-8618.
               doi: 10.1113/JP278810                              doi: 10.7150/thno.46861
            25.  Ting KKY. Fructose-induced metabolic reprogramming of   37.  Li M, Wang Z, Tao J, et al. Fructose-1,6-bisphosphatase 1
               cancer cells. Front Immunol. 2024;15:1375461.      dephosphorylates and inhibits TERT for tumor suppression.
                                                                  Nat Chem Biol. 2024.
               doi: 10.3389/fimmu.2024.1375461
                                                                  doi: 10.1038/s41589-024-01623-3
            26.  Goncalves MD, Lu C, Tutnauer J, et al. High-fructose corn
               syrup enhances intestinal tumor growth in mice.  Science.   38.  Li Y, Fu Y, Zhang Y, et al. Nuclear fructose-1,6-bisphosphate
               2019;363(6433):1345-1349.                          inhibits tumor growth and sensitizes chemotherapy by
                                                                  targeting HMGB1. Adv Sci (Weinh). 2023;10:e2203528.
               doi: 10.1126/science.aat8515
                                                                  doi: 10.1002/advs.202203528
            27.  Patra KC, Hay N. The pentose phosphate pathway and
               cancer. Trends Biochem Sci. 2014;39(8):347-354.  39.  Yang J, Dong C, Wu J, Liu D, Luo Q, Jin X. Fructose utilization
                                                                  enhanced by GLUT5 promotes lung cancer cell migration
               doi: 10.1016/j.tibs.2014.06.005                    via activating glycolysis/AKT pathway.  Clin Transl Oncol.
            28.  Liu H, Huang D, McArthur DL, Boros LG, Nissen N, Heaney   2023;25(4):1080-1090.
               AP. Fructose induces transketolase flux to promote pancreatic      doi: 10.1007/s12094-022-03015-2
               cancer growth. Cancer Res. 2010;70(15):6368-6376.
                                                               40.  Bu P, Chen KY, Xiang K, et al. Aldolase B-mediated fructose
               doi: 10.1158/0008-5472.CAN-09-4615                 metabolism  drives  metabolic  reprogramming  of  colon
            29.  Lodge M, Scheidemantle G, Adams VR,  et  al. Fructose   cancer liver metastasis. Cell Metab. 2018;27:1249-1262.
               regulates  the  pentose  phosphate  pathway  and  induces  an      doi: 10.1016/j.cmet.2018.04.003
               inflammatory and resolution phenotype in Kupffer cells. Sci
               Rep. 2024;14:4020.                              41.  Kim J, Kang J, Kang YL,  et al. Ketohexokinase-A acts as
                                                                  a nuclear protein kinase that mediates fructose-induced
               doi: 10.1038/s41598-024-54272-w                    metastasis in breast cancer. Nat Commun. 2020;11:5436.
            30.  Ghanem N, El-Baba C, Araji K, El-Khoury R, Usta J,      doi: 10.1038/s41467-020-19263-1
               Darwiche N. The pentose phosphate pathway in cancer:   42.  Kang YL, Kim J, Kwak SB, et al. The polyol pathway and
               Regulation and therapeutic opportunities.  Chemotherapy.   nuclear ketohexokinase A signaling drive hyperglycemia-
               2021;66(5-6):179-191.
                                                                  induced metastasis of gastric cancer.  Exp Mol Med.
               doi: 10.1159/000519784                             2024;56:220-234.
            31.  Jin L, Zhou Y. Crucial role of the pentose phosphate pathway      doi: 10.1038/s12276-023-01153-3
               in malignant tumors (Review). Oncol Lett. 2019;17:4213-4221.
                                                               43.  Ghanbari  Movahed  Z,  Rastegari-Pouyani  M,
               doi: 10.3892/ol.2019.10112                         Mohammadi MH, Mansouri K. Cancer cells change their
                                                                  glucose metabolism to overcome increased ROS: One step
            32.  Jin C, Gong X, Shang Y. GLUT5 increases fructose utilization
               in ovarian cancer. Onco Targets Ther. 2019;12:5425-5436.  from cancer cell to cancer stem cell? Biomed Pharmacother.
                                                                  2019;112:108690.
               doi: 10.2147/ott.s205522
                                                                  doi: 10.1016/j.biopha.2019.108690
            33.  Ma G, Liu S, Cai F,  et  al. Ketohexokinase-A deficiency
               attenuates the proliferation via reducing beta-catenin in   44.  Park GB, Jeong JY, Kim D. GLUT5 regulation by AKT1/3-
                                                                  miR-125b-5p downregulation induces migratory activity
               gastric cancer cells. Exp Cell Res. 2024;438:114038.
                                                                  and drug resistance in TLR-modified colorectal cancer cells,
               doi: 10.1016/j.yexcr.2024.114038                   Carcinogenesis. 2020;41:1329-1340.

            Volume 3 Issue 4 (2024)                         11                              doi: 10.36922/gpd.4171
   27   28   29   30   31   32   33   34   35   36   37